Clinical Trial Update: GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on a GLP-1 receptor agonist exploring effects on albuminuria in patients with type 2 diabetes; study terminated with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Diseases
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University at Buffalo | Conditions: Type2 Diabetes, Kidney Diseases | Phase 4 | Status: TERMINATED | Results posted: 2024-04-16